The Central government has approved Biological E’s Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday. On Tuesday, had reported that Corbevax booster for heterologous first has been approved by the Centre. Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological […]
Read Time : 3 Minutes
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study, said a press release. The study has been accepted and published in Lancet Infectious Diseases, a peer-reviewed high-impact factor […]
Read Time : 2 Minutes
Covaxin booster shot enhances efficacy against Delta, Omicron variants of Covid-19: Study
A study showed that administration of Covaxin booster dose will enhance the vaccine effectiveness against the Delta variant infection and give protection against two Omicron variants of COVID-19. The study by ‘bioRxiv’, an open-access preprint repository for the biological sciences, shared on Tuesday that its study shows that administration of […]
Read Time : 3 Minutes
Germany to recognize Bharat Biotech’s COVAXIN for travel from June 1
German Ambassador to India, Walter J Lindner, on Thursday hailed the German government for recognizing the WHO-listed Bharat Biotech’s COVID vaccine, COVAXIN, for travel to the country starting June 1. World Health Organization (WHO) in November last year issued an emergency use listing (EUL) for COVAXIN, adding to a growing […]
Read Time : 1 Minutes
Bharat Biotech seeks DCGI’s permission to conduct Covaxin booster trials in 2-18 age group
Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said. The company has applied for permission a week ago. It has already conducted trials in the age […]
Read Time : 1 Minutes
Bharat Biotech asked to provide more data on Covid-19 vaccine Covaxin for below 12-year-olds
The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said. This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency […]
Read Time : 2 Minutes
Himachal receives 2.80 lakh COVAXIN doses to vaccinate 15-18 age group from Jan 3
Himachal Pradesh government had received 2.80 lakh COVID-19 vaccine COVAXIN doses to vaccinate its young population of 15-18 age group from January 3. “Vaccination for children under 15-18 years to start from 3rd Jan. We have received 2.80 lakh COVAXIN doses for the same,” State Health Minister Rajiv Saizal told ANI on Wednesday. He further […]
Read Time : 2 Minutes
Covaxin 50 pc effective against symptomatic Covid: Lancet study
Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 percent effective against symptomatic COVID-19 disease, according to the first real-world assessment of the COVID-19 vaccine published in The Lancet Infectious Diseases journal. The study assessed 2,714 hospital workers at the All India Institute of Medical Sciences (AIIMS) in Delhi, from […]
Read Time : 4 Minutes
Covaxin true success story of public-private partnership, says Bharat Biotech Chairman
The development of the country’s indigenous COVID-19 vaccine Covaxin is a true success story for public-private partnerships in India, which is based on mutual respect, trust and transparency, said Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech. Speaking at the launch of “Going Viral, Making of Covaxin: The Inside Story” book, Dr Ella […]
Read Time : 2 Minutes
Travellers vaccinated with Covaxin can enter US
Travellers fully vaccinated against COVID-19 with Covaxin have been given the green light to enter the US from November 8. Talking to ANI over updating the approved travel list for Covaxin, CDC press officer, Scott Pauley said, “CDC’s travel guidance applies to FDA approved or authorized and WHO Emergency Use Listing vaccines and encompasses any new vaccines that may be added […]
Read Time : 2 Minutes
Australia adds Covaxin to list of ‘recognised’ Covid-19 vaccines
Australian government on Monday gave recognition to Bharat Biotech’s Covaxin COVID-19 vaccine for the purpose of establishing a traveller’s vaccination status in the country. “Today, the Therapeutic Goods Administration determined that Covaxin (manufactured by BharatBiotech) vaccine would be ‘recognised’ for the purpose of establishing a traveller’s vaccination status,” Australia’s High […]
Read Time : 1 Minutes
Approval to Covaxin for children aged between 2-18 years
After the evaluation of data, Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources. Bharat Biotech, the manufacturer of Covaxin, has submitted data for clinical trials in the age group of 2-18 years to Central Drugs Standard […]
Read Time : 2 Minutes
WHO to decide on Bharat Biotech’s Covaxin emergency usage in October
The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech’s submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021. The status of assessment for Covaxin is “ongoing” as of now, the WHO informed in a document citing […]
Read Time : 2 Minutes
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine efficacy of 78.8 pc against Covid-19
Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 percent effective against COVID-19. It also added that Covaxin gives 65.2 percent protection against the SARS-CoV-2, B.1.617.2 Delta variant. “Efficacy analysis demonstrates Covaxin to be 77.8 percent effective against symptomatic COVID-19, through […]
Read Time : 2 Minutes
People struggling, travelling long distances to get COVAXIN dose
As people are struggling to book slots for COVID-19 vaccination in their cities, many of them who are in less than 45 years age group from Delhi-NCR are travelling a long distance to get their first and even second dose of COVAXIN. These people are even travelling distance of 224 km from Delhi and […]